Several studies reported that PGAM1 is overexpressed in various cancers, including hepatocellular carcinoma (30), lung cancer (31), breast cancer (32), prostate cancer (22) and renal clear cell carcinoma (33). Here, PGAM1 is linked to clear cell renal carcinoma.